Table 1.
Demographics and treatment site for included children
| Demographics | N (%) or median (IQR) | |||
|---|---|---|---|---|
| Period | ||||
| Overall (N = 1228) | Baseline (N = 397) | PNAFish (n = 408) | rmPCR (N = 422) | |
| Male | 709 (58%) | 213 (54%) | 242 (59%) | 253 (60%) |
| Age, years | 2 (0–8) | 2 (0–7) | 2 (0–8) | 2 (0–7) |
| Central line in place | 447 (36%) | 161 (41%) | 149 (37%) | 137 (32%) |
| Patient location at time 0 | ||||
| Admitted | 984 (80%) | 308 (78%) | 330 (81%) | 345 (82%) |
| General wards | 422 (34%) | 130 (33%) | 141 (35%) | 150 (36%) |
| ICU (PICU/CICU)a | 246 (20%) | 75 (19%) | 83 (20%) | 88 (21%) |
| NICUb | 131 (12%) | 42 (11%) | 44 (11%) | 45 (11%) |
| ICSc | 176 (14%) | 57 (14%) | 60 (15%) | 59 (14%) |
| Other | 9 (1%) | 4 (1%) | 2 (0%) | 3 (1%) |
| Not admitted | 244 (20%) | 89 (22%) | 78 (19%) | 77 (18%) |
| No active encounter | 216 (18%) | 78 (20%) | 68 (17%) | 70 (17%) |
| ED/RTUd | 28 (2%) | 11 (3%) | 10 (2%) | 7 (2%) |
a ICU intensive care unit; PICU pediatric ICU; CICU cardiac ICU
b NICU neonatal ICU
cImmune compromised unit: unit for patients with malignancy, organ transplantation or other immune compromising condition
d RTU rapid treatment (short stay) unit